Oct 26, 11 03:14AM
|
0 comments
The September 2011 issue of the Journal of Clinical Psychiatry created history in two ways.
First, the journal published this article written by FDA staff critically reviewing the efficacy and safety data of Viibryd, a new antidepressant that the same FDA staff had just approved.
Second, it was not just any journal that published the article, but the Journal of Clinical Psychiatry. Why is
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.